Abstract
Modern medical science
has been greatly advanced by the development of new drugs, despite the fact
that the process of developing new drugs is costly and time-consuming. An
accurate prediction method for the drug-likeness in the early stage of drug
discovery is highly desirable, as it will facilitate the discovery process and
reduce the overall cost and eventually contribute to human well-being. Based on
a central nervous system (CNS) drug dataset, we constructed an artificial
neural network (NN) to predict the CNS drug-likeness of a given bioactive compound.
We first constructed a simple feed-forward neural network, to learn and predict
the possible correlations between twelve physiochemical properties and the CNS
drug-likeness. The accuracy of prediction has reached 80%, which has been
improved from previous reports. We further constructed a neural network based
on chemical structure, and the accuracy has increased to 86%. The successful
prediction of the CNS drug-likeness renders this NN a powerful tool for virtual
drug screening.